Table 1.
Protein | Cellular localization | Illustrative antiviral activitya | References |
---|---|---|---|
Human MxA | Cytoplasmic condensates with some tethered to intermediate filaments | Versus both FLUAV and VSV | 9, 29,30, 31, 32, 33, 34,35 |
Human MxB (full-length) | Cytoplasmic face of nuclear pores | Versus HIV; not versus FLUAV nor VSV | 31, 39,40, 41, 42, 43,44 |
Cytoplasmic condensates | Our inference | ||
Murine Mx1 | Nuclear condensates | Versus FLUAV; not VSV | This study and Refs. 29–31, 35, 36 |
Cytoplasmic intermediate filaments and condensates | Versus VSV | This study | |
Murine Mx2 | Cytoplasmic structures | Versus VSV; not FLUAV | 31, 35–37 |